Harnessing the Power of Artificial Intelligence in Clinical Trials and Disease Modeling: Challenges and Future Directions
DOI:
https://doi.org/10.47941/jts.2657Keywords:
Artificial Intelligence, Clinical Trials, Disease Modeling, Machine Learning, Precision Medicine, Risk Stratification, Personalized Medicine, Efficiency, Ethical Challenges, Privacy, Prediction.Abstract
Purpose: This article explores the potential of artificial intelligence (AI) to transform clinical trials and disease modeling, focusing on how AI can enhance healthcare efficiency, precision, and personalization.
Methodology: The study involves reviewing existing literature and conducting detailed investigations of various AI models, ranging from basic machine learning algorithms to sophisticated deep learning models like convolutional neural networks (CNNs), recurrent neural networks (RNNs), generative adversarial networks (GANs), and transformer models.
Findings: Our analysis demonstrates that AI algorithms can significantly reduce human screening time, improve risk stratification, and provide more accurate predictions compared to conventional techniques [17], [18]. However, these benefits are accompanied by challenges, including data quality issues, algorithmic bias, understanding the "black box" nature of AI tools, regulatory constraints, and patient privacy and consent concerns.
Unique Contribution to Theory, Practice, and Policy: The article highlights AI's enormous potential to revolutionize clinical research. It recommends that successful implementation requires collaboration with the medical community to ensure ethical and responsible use, addressing the challenges of data quality, transparency, regulatory compliance, and patient rights.
Downloads
References
S. M. Varnosfaderani and M. Forouzanfar, “The Role of AI in Hospitals and Clinics: Transforming Healthcare in the 21st Century,” Mar. 29, 2024, Multidisciplinary Digital Publishing Institute. doi: 10.3390/bioengineering11040337.
S. A. Alowais et al., “Revolutionizing healthcare: the role of artificial intelligence in clinical practice,” BMC Medical Education, vol. 23, no. 1. BioMed Central, Sep. 22, 2023. doi: 10.1186/s12909-023-04698-z.
I. N. Weerarathna, A. R. Kamble, and A. Luharia, “Artificial Intelligence Applications for Biomedical Cancer Research: A Review,” Cureus. Cureus, Inc., Nov. 05, 2023. doi: 10.7759/cureus.48307.
S. Harrer, P. Shah, B. Antony, and J. Hu, “Artificial Intelligence for Clinical Trial Design,” Trends in Pharmacological Sciences, vol. 40, no. 8. Elsevier BV, p. 577, Jul. 17, 2019. doi: 10.1016/j.tips.2019.05.005.
X. Lu, C. Ming-an, Z. Lu, X. Shi, and L. Liang, “Artificial intelligence tools for optimising recruitment and retention in clinical trials: a scoping review protocol,” BMJ Open, vol. 14, no. 3. BMJ, Mar. 01, 2024. doi: 10.1136/bmjopen-2023-080032.
A. Cundari, “How Artificial Intelligence (AI) is Revolutionizing Clinical Trials.” Sep. 2024. Accessed: Mar. 15, 2025. [Online]. Available: https://www.linical.com/articles-research/how-ai-is-revolutionizing-clinical-trials
X. Lu, Y. Chen, L. Liang, G. Hu, Z. Zhong, and Z. Jiang, “Artificial intelligence for optimizing recruitment and retention in clinical trials: a scoping review,” Journal of the American Medical Informatics Association. Oxford University Press, Sep. 11, 2024. doi: 10.1093/jamia/ocae243.
Q. Jin et al., “Matching Patients to Clinical Trials with Large Language Models,” Jan. 01, 2023, Cornell University. doi: 10.48550/arxiv.2307.15051.
P. Tappenden, J. Chilcott, A. Brennan, H. Squires, R. Glynne‐Jones, and J. Tappenden, “Using Whole Disease Modeling to Inform Resource Allocation Decisions: Economic Evaluation of a Clinical Guideline for Colorectal Cancer Using a Single Model,” Value in Health, vol. 16, no. 4. Elsevier BV, p. 542, May 16, 2013. doi: 10.1016/j.jval.2013.02.012.
S. F. Cook and R. R. Bies, “Disease Progression Modeling: Key Concepts and Recent Developments,” Aug. 14, 2016, Springer Science+Business Media. doi: 10.1007/s40495-016-0066-x.
A. Visibelli, B. Roncaglia, O. Spiga, and A. Santucci, “The Impact of Artificial Intelligence in the Odyssey of Rare Diseases,” Biomedicines, vol. 11, no. 3. Multidisciplinary Digital Publishing Institute, p. 887, Mar. 13, 2023. doi: 10.3390/biomedicines11030887.
P. Dey, C. Ogwo, and M. Téllez, “Comparison of traditional regression modeling vs. AI modeling for the prediction of dental caries: a secondary data analysis,” May 24, 2024, Frontiers Media. doi: 10.3389/froh.2024.1322733.
M. Wojtara, E. Rana, T. Rahman, P. Khanna, and H. Singh, “Artificial intelligence in rare disease diagnosis and treatment,” Clinical and Translational Science, vol. 16, no. 11. Wiley, p. 2106, Aug. 30, 2023. doi: 10.1111/cts.13619.
M. A. Al-antari, “Artificial Intelligence for Medical Diagnostics—Existing and Future AI Technology!,” Diagnostics, vol. 13, no. 4. Multidisciplinary Digital Publishing Institute, p. 688, Feb. 12, 2023. doi: 10.3390/diagnostics13040688.
C. Kelly, A. Karthikesalingam, M. Suleyman, G. S. Corrado, and D. King, “Key challenges for delivering clinical impact with artificial intelligence,” Oct. 29, 2019, BioMed Central. doi: 10.1186/s12916-019-1426-2.
B. Bhinder, C. Gilvary, N. S. Madhukar, and O. Elemento, “Artificial Intelligence in Cancer Research and Precision Medicine,” Cancer Discovery, vol. 11, no. 4. American Association for Cancer Research, p. 900, Apr. 01, 2021. doi: 10.1158/2159-8290.cd-21-0090.
A. Shuaib, “Transforming Healthcare with AI: Promises, Pitfalls, and Pathways Forward,” May 01, 2024, Dove Medical Press. doi: 10.2147/ijgm.s449598.
C. Giordano, M. Brennan, B. Mohamed, P. Rashidi, F. Modave, and P. Tighe, “Accessing Artificial Intelligence for Clinical Decision-Making,” Frontiers in Digital Health, vol. 3. Frontiers Media, Jun. 25, 2021. doi: 10.3389/fdgth.2021.645232.
F. Mirakhori and S. K. Niazi, “Harnessing the AI/ML in Drug and Biological Products Discovery and Development: The Regulatory Perspective,” Oct. 31, 2024. doi: 10.20944/preprints202410.2510.v1.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Isham Kalappurackal Mansoor, Mansoor Veliyathnadu Ebrahim
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
